D. Jacques Smith

Client Work

Jacques represents domestic, foreign, and sovereign clients in complex internal investigations and civil litigation at all levels in both federal and state courts. He also frequently advises these clients on their rights and liabilities before litigation arises. He has substantial experience in responding to government subpoenas and civil investigative demands (CIDs) as well as supervising a nationwide litigation docket of complex cases arising in multiple states. More than 50 of Jacques’ cases have been reported.

Selected significant matters include:

• Representation of a large public hospital in the resolution of a $70 million False Claims Act and Stark Law litigation in United States ex rel. Reilly v. North Broward Hospital District (USDC SD Fla.)
• For more than 17 years, served as lead litigation counsel representing a global pharmaceutical manufacturer in connection with the Average Wholesale Price MDL throughout the country in In re Pharmaceutical Industry Average Wholesale Litigation (MDL No. 1456)

• Served as lead counsel representing a large, international pharmaceutical company in an investigation brought by the US Attorney for the District of Massachusetts and DOJ alleging violations of the False Claims Act and possible violations of the Federal Food, Drug, and Cosmetic Act in United States ex rel. Albermarle v. Cipla, et al. (DOJ; USDC D. Mass)

• Obtained dismissal on behalf of a global pharmaceutical company in two related litigations alleging violations of the False Claims Act (United States ex rel. John R. Borzilleri, M.D., et al v. Abbvie, Inc., et al.) (USDC SDNY and DRI; 1st Cir. and 2nd Cir.)
• Obtained declination of two proton therapy centers in a False Claims Act, Stark Law, and Anti-Kickback Statute investigation in United States ex. rel. Ward v. ProCure Management (USDC WD Ok.)
• Obtained declination on behalf of the former president of a benefit management company in a False Claims Act investigation (the former company entered into a $54 million settlement) (USDC SDNY)
• Served as lead counsel representing multiple entities in investigations brought by the US Attorney for the District of Massachusetts into whether pharmaceutical manufacturers and patient assistance programs violated the Anti-Kickback Statute and False Claims Act relating to the provision of co-pays, obtaining declination of one entity (DOJ; USDC D. Mass)
• Obtained dismissal of a financial institution in a False Claims Act lawsuit asserting billions of dollars in claims in United States ex. rel. Brown and Stone v. BankUnited Trust (USDC SD Fla.)
• Obtained favorable settlements on behalf of multiple pharmaceutical companies in pricing disputes alleging fraudulent Medicaid reimbursements in State of Louisiana v. Abbott Laboratories, et al. (19th Judicial District; 1st Cir.; Supreme Court (LA))
• Obtained declination on behalf of an international medical device manufacturer in an investigation by the DOJ Consumer Protection Branch and the United States Attorney’s Office for the District of Massachusetts into False Claims Act allegations and possible criminal or civil violations of the Federal Food, Drug, and Cosmetic Act in United States v. Coloplast et al. (USDC D. Mass)
• Obtained dismissal of a major pharmaceutical company in a False Claims Act litigation in United States, ex rel. Conrad v. Actavis Mid-Atlantic, et al. (USDC D. Mass)
• Obtained dismissal of a public hospital in four False Claims Act Cases where its former General Counsel brought suit (Sup. Ct. Cal.; USDC ND Cal.)
• Representation of a major hospital in connection with a proposed Government audit and complex administrative subpoena (USDC ED Pa.; 3rd Cir.)
• Representation of a major urban hospital in connection with a False Claims Act case (USDC DDC)
• Obtained dismissal of a vaccine manufacturer in a False Claims Act litigation in Dingle v. BioPort Corp. (USDC WD Mich.; 6th Cir.; USSC)
• Obtained summary judgment in favor of a generic pharmaceutical company in a patent case in Glaxo v. Impax Laboratories (USDC ND Cal.)
• Obtained dismissal on behalf of a major vaccine producer in a challenge brought by military service members in Bates v. BioPort Corp. (USDC DDC)
• Representation of a major pharmaceutical company in connection with patent and unfair competition litigation (USDC MD)

Celebrating ArentFox Schiff’s Veterans: Jacques Smith on Going From Military Service to Client Service

In 1990, Jacques began his career as a litigator while serving with the Judge Advocate General’s Corps of the United States Navy. As a US Navy attorney, Jacques served as a prosecutor, chief defense counsel, and appellate defense counsel while being stationed throughout the world. He gained extensive litigation experience, trying hundreds of courts-martial at trial and on appeal. Jacques later served in the Navy’s General Litigation Division, representing the Navy’s and Department of Defense’s interests in federal district courts and courts of appeal throughout the country, the US Court of Claims, and the Federal Circuit. Following his affiliation with ArentFox Schiff in 1996, Jacques continued his service as a reserve officer in several roles. Jacques served as Commanding Officer (acting) and Executive Officer of the Regional Legal Service Office for Naval District Washington, as a General Court – Martial Military Judge, as the Chief Judge of the Navy Reserve Trial Judiciary, and as an Appellate Judge on the Navy-Marine Corps Court of Criminal Appeals.

Jacques was named the American Bar Association’s Outstanding Young Naval Attorney in 1993 and has been awarded the Legion of Merit, three Meritorious Service Medals, five Navy Commendation Medals, the Navy Achievement Medal, and multiple Secretarial and Flag Letters of Commendation for outstanding military and professional service. He was promoted to Captain in the United States Navy in 2009 and retired from the Navy with 30 years of service in 2020.

Jacques was designated a Litigation Expert by the Navy Judge Advocate General Corps’ Military Justice Litigation Career Track Selection Board in 2009. He has taken several advanced classes at the National Judicial College and served as an adjunct faculty member at the Naval Justice School and Army’s Judge Advocate General School for many years, focusing on evidence, trial practice, and judicial methodology. As a result, Jacques was recognized with an AV Preeminent® judicial rating.

Read more

Publications, Presentations & Recognitions

Jacques is committed to public service matters. In 2000 he was awarded the firm’s Albert Arent Pro Bono Award for outstanding commitment to community service and pro bono interests. In 2018 and again in 2021, he was awarded the Marc L. Fleischaker Award for his outstanding work on pro bono matters. Chambers USA and Legal 500 US have consistently recognized him for his litigation and investigations work in the health care industry.

Jacques is a regular writer, speaker, and commentator on a variety of government investigations, False Claims Act, and litigation best practices nationwide. He is the co-author of multiple chapters of a PLI book on government investigations, litigation, and health care fraud. He has also co-written (with Michael Dearington and Randall Brater) “Eleventh Circuit Deals Blow to Defense Contractors in Key False Claims Act Statute-of-Limitations Tolling Case, Deepening Circuit Split” and (with Michael Dearington) “Catch Me If You Can: The Divergent and Inconstant Pleading Requirements Governing Qui Tam Complaints.”

Jacques has also been frequently interviewed or quoted in industry publications, including:

“Q&A: FCA Specialist Jacques Smith on Perils, Precautions for Health Care Industry,” The National Law Journal, May 12, 2021, “Mischievous activity during the pandemic will lead to more healthcare fraud recoveries in 2021,” Healthcare Finance, March 16, 2021, “Sixth Circuit Offers New Clarity for Copycat Fraud Cases,” Bloomberg Law, January 29, 2021, “Distilling Compliance Lessons from Healthcare Fraud Cases,” Compliance Week, January 24, 2019, “DOJ’s Slumping FCA Hauls Cloud Future Recovery Prospects,” Law360, January, 11, 2019, and “Damages Could Pile Up if High Court Affirms False Claims Ruling,” Bloomberg Law, January 4, 2019.

Jacques’ recent client alerts and blog articles include:

• “NYC Couple Pleads Guilty to Multi-Billion Dollar Cryptocurrency Conspiracy.”
• “Former NBA Player Sentenced to 10 Years in Prison for Health Care Fraud.”
• “Vitamin Company to Pay Over $1 Million in Penalties for Deceptive Marketing of Purported COVID-19 Treatments.”
• “$140 Million Healthcare Fraud Case to Be Retried.”
• “Recent Filings Shed Light on DOJ’s View of Supreme Court’s Recent FCA Ruling.”
• “Court Unseals Charges Alleging Nearly $15 Million in Fraudulent PPP Loans.”
• “Government Wins $43 Million Verdict in False Claims Act Case.”
• “$31 Million Medicare Fraud Scheme Results in Two Convictions.”
• “Guilty Plea in $250 Million Federal Child Nutrition Fund Fraud Scheme.”
• “Jury Finds LabSolutions CEO Guilty in $463 Million Telemed Billing Scheme.”
• “DOJ Announces $3.3 Billion Cryptocurrency Seizure and Fraud Conviction.”
• “Dozens Charged in $1.2 Billion Nationwide Telemedicine and DME Fraud Scheme.”
• “Financial Asset Managers Charged in $1.2 Billion International Money Laundering Scheme.”